E
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Emcure Pharmaceuticals Ltd
NSE:EMCURE
Price:
1 390
INR
-4.5%
Market Closed
Market Cap:
₹263.5B
Cash Flow Statement
Cash Flow Statement
Emcure Pharmaceuticals Ltd
Emcure Pharmaceuticals Ltd
Currency: INR
| Sep-2024 | Mar-2025 | Sep-2025 | ||
|---|---|---|---|---|
| Operating Cash Flow | ||||
| Net Income |
8 187
|
9 713
|
11 227
|
|
| Depreciation & Amortization |
3 654
|
3 841
|
3 977
|
|
| Stock-Based Compensation |
0
|
20
|
0
|
|
| Other Non-Cash Items |
2 320
|
1 674
|
856
|
|
| Cash Taxes Paid |
2 604
|
2 469
|
3 197
|
|
| Cash Interest Paid |
1 959
|
1 287
|
775
|
|
| Change in Working Capital |
(5 130)
|
(6 712)
|
(8 583)
|
|
| Cash from Operating Activities |
9 032
N/A
|
8 517
-6%
|
7 477
-12%
|
|
| Investing Cash Flow | ||||
| Capital Expenditures |
(3 411)
|
(4 069)
|
(4 032)
|
|
| Other Items |
(1 215)
|
3 129
|
(2 367)
|
|
| Cash from Investing Activities |
(4 626)
N/A
|
(940)
+80%
|
(6 399)
-581%
|
|
| Financing Cash Flow | ||||
| Net Issuance of Common Stock |
7 526
|
7 792
|
187
|
|
| Net Issuance of Debt |
(5 814)
|
(14 645)
|
3 146
|
|
| Cash Paid for Dividends |
0
|
0
|
(569)
|
|
| Other |
(2 382)
|
(1 287)
|
(775)
|
|
| Cash from Financing Activities |
(670)
N/A
|
(8 140)
-1 115%
|
1 989
N/A
|
|
| Change in Cash | ||||
| Effect of Foreign Exchange Rates |
(19)
|
(20)
|
91
|
|
| Net Change in Cash |
3 717
N/A
|
(583)
N/A
|
3 157
N/A
|
|
| Free Cash Flow | ||||
| Free Cash Flow |
5 621
N/A
|
4 448
-21%
|
3 445
-23%
|
|
Switch to:
Switch to:
See Also
Discover More
